| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8444109 | European Journal of Cancer | 2013 | 7 Pages |
Abstract
Pazopanib demonstrated efficacy in patients with metastatic ccRCC after PD with other TTs. Toxicity overall was mild/moderate and manageable.
Keywords
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
M.R. Matrana, C. Duran, A. Shetty, L. Xiao, B.J. Atkinson, P. Corn, L.C. Pagliaro, R.E. Millikan, C. Charnsangave, E. Jonasch, N.M. Tannir,